Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06914596 · ClinicalTrials.gov registry record · NA

A Clinical Trial Comparing Overnight and 2x/Day for 30-minutes Use of the Emanate Perio PODS Post-SRP

A NA study of Periodontitis (Stage 3), sponsored by McGuire Institute.

Recruiting
Registry status
NA
Development phase
111
Enrollment target
10
Study locations

NCT06914596 is a NA study of Periodontitis (Stage 3) that is actively recruiting participants, run by McGuire Institute. The registered enrollment target is 111 participants. The trial reports 10 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06914596, a NA study of Periodontitis (Stage 3), is actively recruiting participants, sponsored by McGuire Institute.

RECRUITING
Registry status
NA
Development phase
111 participants
Enrollment target
10
Study locations

Study Summary

The goal of this clinical trial is to compare safety and to see if individuals with generalized stage III periodontitis that are given a periodontal hydrogel dressing on a wound healing after plaque and tartar have been removed from teeth have greater healing than individuals who are given no treatment after.

Conditions Studied

Interventions

  • DEVICE Emanate Perio PODS

Study Locations (10)

Texas

  • Perio Health Professionals - Houston
  • Perio Health Professionals - Houston
  • Periodontal Center of Excellence, PLLC - Spring
  • Gulf Coast Periodontics - Victoria

California

  • Regenerative Solutions - Fullerton

Connecticut

  • Shoreline Periodontics and Dental Implants - New London

Massachusetts

  • The Perio Studio - Boston

Nebraska

  • Metro West Orthodontics & Periodontics - La Vista

Virginia

  • Glazier Implants + Periodontics - Richmond

Washington

  • Seattle Periodontist and Implant Dentistry - Seattle

Trial Details

FieldValue
Enrollment Target 111 participants
Start Date 2026-02-19
Est. Completion 2027-01-30
Phase NA

Sponsor

McGuire Institute

7 total trials

What the Registry Record Tells You About NCT06914596

The ClinicalTrials.gov registry entry for NCT06914596 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 111 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is McGuire Institute, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Periodontitis (Stage 3) appearing as the primary indexed condition, and to 1 intervention - of which Emanate Perio PODS is the first listed.

NCT06914596 reports 10 study locations spanning 7 distinct geographic areas - top geographies include Texas, California, Connecticut.

Frequently Asked Questions

What is clinical trial NCT06914596 about?

NCT06914596 is a clinical study titled "A Clinical Trial Comparing Overnight and 2x/Day for 30-minutes Use of the Emanate Perio PODS Post-SRP". The goal of this clinical trial is to compare safety and to see if individuals with generalized stage III periodontitis that are given a periodontal hydrogel dressing on a wound healing after plaque and tartar have been removed from teeth have greater healing than individuals who are given no treatm...

What is the current status of trial NCT06914596?

This trial is currently recruiting. It is a NA study. The enrollment target is 111 participants. The study started on 2026-02-19. Estimated completion is 2027-01-30.

What conditions does trial NCT06914596 study?

This clinical trial studies the following conditions: Periodontitis (Stage 3).

What interventions are being tested in trial NCT06914596?

The interventions under investigation include: Emanate Perio PODS (DEVICE).

Who is sponsoring clinical trial NCT06914596?

This trial is sponsored by McGuire Institute, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06914596 being conducted?

This trial has 10 study locations across California, Connecticut, Massachusetts, Nebraska, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.